Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s12072-020-10043-z http://scihub22266oqcxt.onion/10.1007/s12072-020-10043-z 32277387!7146012!32277387     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 265.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Hepatol+Int 2020 ; 14 (4): 432-436 Nephropedia Template TP {{tp|p=32277387|t=2020. Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation |pdf=|usr=}}{{32277387}} gab.com Text Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation JO: Hepatol Int http://www.kidney.de/pget.php?&tw=1&pmid=32277387 #FOAvip Annually, around 850 liver transplantation is performed in Beijing, China. Recently, the new coronavirus pneumonia (COVID-19) caused by 2019 novel coronavirus (2019-nCoV) has affected nearly 200 countries worldwide. 2019-nCov can cause severe lung disease, multiple-organ damage, and significant mortalities. Liver transplant recipients, because of long-term oral immunosuppressant effects, may be more susceptible to 2019-nCoV infection and have a worse prognosis than the general population. It is urgent to set up guidelines for the prevention, diagnosis, and treatment of COVID-19 in liver transplant recipients. In this article, we reviewed the clinical aspects of 2019-nCoV infection, characteristics of liver transplant recipients, immunosuppressant usage, and potential drug interactions to provide recommendations to clinical staff managing liver transplant recipients during the COVID-19 epidemic. Twit Text FOAVip Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation ????Hepatol Int http://www.kidney.de/pget.php?&tw=1&pmid=32277387 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32277387 #FOAvip English Wikipedia <ref>{{Cite pmid|32277387}}</ref> Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation #MMPMID32277387 Liu H; He X; Wang Y; Zhou S; Zhang D; Zhu J; He Q; Zhu Z; Li G; Sun L; Wang J; Cheng G; Liu Z; Lau G Hepatol Int 2020[Jul]; 14 (4): 432-436 PMID32277387show ga Annually, around 850 liver transplantation is performed in Beijing, China. Recently, the new coronavirus pneumonia (COVID-19) caused by 2019 novel coronavirus (2019-nCoV) has affected nearly 200 countries worldwide. 2019-nCov can cause severe lung disease, multiple-organ damage, and significant mortalities. Liver transplant recipients, because of long-term oral immunosuppressant effects, may be more susceptible to 2019-nCoV infection and have a worse prognosis than the general population. It is urgent to set up guidelines for the prevention, diagnosis, and treatment of COVID-19 in liver transplant recipients. In this article, we reviewed the clinical aspects of 2019-nCoV infection, characteristics of liver transplant recipients, immunosuppressant usage, and potential drug interactions to provide recommendations to clinical staff managing liver transplant recipients during the COVID-19 epidemic. |*Betacoronavirus[MESH] |*Liver Transplantation[MESH] |COVID-19[MESH] |China[MESH] |Coronavirus Infections/*complications/*diagnosis/therapy[MESH] |Humans[MESH] |Liver Diseases/*diagnosis/etiology/*therapy[MESH] |Pandemics[MESH] |Patient Selection[MESH] |Pneumonia, Viral/*complications/*diagnosis/therapy[MESH] |Practice Guidelines as Topic[MESH] |SARS-CoV-2[MESH] |Societies, Medical[MESH]Management of COVID-19 in patients after liver transplantation: Beijin(epmc).pdf DeepDyve Pubget Overpricing